Glucoset - About the company
Glucoset is an acquired company based in Trondheim (Norway), founded in 2013. It operates as an Indwelling intravascular continuous blood glucose monitoring device. Glucoset has raised $6.59M in funding from Diabetes Venture Fund. The company has 1012 active competitors, including 219 funded and 65 that have exited. Its top competitors include companies like Withings, Ultrahuman and Dexcom.
Company Details
Indwelling intravascular continuous blood glucose monitoring device. The GlucoSet intravascular sensor delivers continuous and accurate information on patient's blood glucose level, enabling normalization of glucose levels, without the risk of sudden and dangerously low glucose levels. By accessing through an indwelling arterial catheter without disrupting that catheter's current use, the GlucoSet sensor requires no new catheters and displaces no other equipment. The company claims that unlike competing solutions, the sensor also tolerates patient movement very well. The company also claims that with a sensor cross sectional area under 5% of the smallest competing product, GlucoSet is the first sensor able to access through arterial catheters without risk.
Key Metrics
Founded Year
2013
Location
Trondheim, Norway
Stage
Acquired
Total Funding
$6.59M in 8 rounds
Latest Funding Round
Investors
Ranked
128th among 1012 active competitors
Employee Count
16 as on Apr 30, 2026
Exit Details
Acquired by Televenture (Apr 09, 2015)
Legal entities associated with Glucoset
Glucoset is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Glucoset As CIN: 997780922 , India, Active | Dec 18, 2011 | $0 - $1M (As on Dec 31, 2021) | 19 (As on Dec 31, 2021) | |
GLUCOSET AS CIN: 997780922 , Norway, Active | Dec 18, 2011 | - | 20 (As on Dec 31, 2022) |
Glucoset's acquisition details
Glucoset got acquired by Televenture on Apr 09, 2015.
Click here to take a look at Glucoset's acquisition in detail
Sign up to download Glucoset's company profile
Glucoset's funding and investors
Glucoset has raised a total funding of $6.59M over 8 rounds. Its first funding round was on Jun 01, 2016. Its latest funding round was a Grant (prize money) round on Jul 07, 2023 for $*****. 2 investors participated in its latest round. Glucoset has 6 institutional investors.
Here is the list of recent funding rounds of Glucoset:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 07, 2023 | 2910513 | Grant (prize money) | 5845903 | 5005737 | 5733149 | 9103102 |
Jul 07, 2023 | 8445094 | Series A | 6522474 | 5749805 | 2020976 | 5088743 |
Nov 30, 2020 | 3060990 | Grant (prize money) | 3819224 | 8097839 | 9651475 |
View details of Glucoset's funding rounds and investors
Glucoset's founders and board of directors
Founder? Claim ProfileGlucoset's employee count trend
Glucoset has 16 employees as of Apr 26. Here is Glucoset's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Glucoset's Competitors and alternates
Top competitors of Glucoset include Withings, Ultrahuman and Dexcom. Here is the list of Top 10 competitors of Glucoset, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of an array of connected products | $93.8M | 83/100 | ||
2nd | Ultrahuman 2019, Bengaluru (India), Series C | Provider of wearable health trackers and metabolic monitoring hardware devices | $103M | 81/100 | |
3rd | Dexcom 1999, San Diego (United States), Public | Provider of a wearable device for glucose monitoring | $52.7M | 79/100 | |
4th | Developer of a smart ring for sleep, fitness, stress, and health | $1.32B | 79/100 | ||
5th | Insulet 2000, Boston (United States), Public | Manufacturer of wearable, tubeless insulin delivery systems for diabetes management | $120M | 77/100 | |
6th | Senseonics 1996, Germantown (United States), Public | Provider of implantable systems for continuous glucose monitoring | $165M | 71/100 | |
7th | Livongo 2014, San Francisco (United States), Acquired | Provider of smart devices for diabetes management for patients and doctors | $245M | 70/100 | |
8th | One Drop 2015, New York City (United States), Series C | Provider of workforce healthcare solutions | $108M | 70/100 | |
9th | Signos 2020, San Francisco (United States), Series B | Provider of a wearable device for blood glucose pattern monitoring | $37M | 69/100 | |
10th | Provider of diabetes care and reversal programs | $26.7M | 68/100 | ||
128th | Indwelling intravascular continuous blood glucose monitoring device | $6.59M | 41/100 |
Looking for more details on Glucoset's competitors? Click here to see the top ones
Glucoset's Investments and acquisitions
Glucoset has made no investments or acquisitions yet.
News related to Glucoset
•
Medtech startup GlucoSet raises €6M in series Afox59.com•Jul 07, 2023•Glucoset, Diabetes Venture Fund
Are you a Founder ?
FAQs about Glucoset
Explore our recently published companies
- Ridgeroad - Unfunded company
- Lbgadvisors - 2002 founded, Unfunded company
- ROFF Ties & Cuffs - Singapore based, 2006 founded, Deadpooled company
- Metzler Switzerland - Switzerland based, Unfunded company
- Thomasnayler - United Kingdom based, Unfunded company
- Wildlandservices - Auburn based, 2009 founded, Unfunded company